Publications by authors named "W F VIA"
Introduction: Respiratory syncytial virus (RSV) is the leading cause of hospitalization among US infants. Characterizing service utilization during infant RSV hospitalizations may provide important information for prioritizing resources and interventions.
Objective: The objective of this study was to describe the procedures and services received by infants hospitalized during their first RSV episode in their first RSV season, in addition to what proportion of infants died during this hospitalization.
Article Synopsis
- Respiratory syncytial virus (RSV) poses significant health risks to infants in the US, with exposure timing linked to their birth month; some months lead to higher risks of serious lower respiratory tract infections (LRTI).
- A study analyzed insurance claims from infants born between July 2016 and February 2020, focusing on their first RSV season and the medical attention required for RSV LRTI, revealing varying risks based on birth month.
- Infants born from May to September faced the highest risks of medically attended RSV LRTI during their first season, while those born from October to December had higher hospitalization rates; findings support the use of nirsevimab to mitigate these risks.
Introduction: New extended half-life antibodies for the single-dose prevention of medically attended (MA) respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) have been developed for administration to all infants before or during their first RSV season. For infants born during the season, administration as soon as feasible after birth would provide optimal protection and minimize access disparities. The objective of this study was to assess the time from birth hospitalization discharge to the first outpatient visit (FOV) among US infants in order to determine optimal site of administration for the extended half-life antibody.
View Article and Find Full Text PDFBackground: Respiratory syncytial virus (RSV) is a leading cause of infant hospitalization in the United States. Preterm infants and those with select comorbidities are at highest risk of RSV-related complications. However, morbidity due to RSV infection is not confined to high-risk infants.
View Article and Find Full Text PDFThis study was conducted to survey US pediatric specialists about administration of respiratory syncytial virus (RSV) immunoprophylaxis, communication patterns among physicians and parents, and barriers to access. Separate surveys were sent to neonatologists, pediatricians, pediatric pulmonologists, and pediatric cardiologists. Most physicians (≥93.
View Article and Find Full Text PDF